dapsone has been researched along with Alzheimer Disease in 4 studies
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| McLarnon, JG | 1 |
| Lee, JH | 1 |
| An, HK | 1 |
| Sohn, MG | 1 |
| Kivela, P | 1 |
| Oh, S | 1 |
| Oken, RJ | 1 |
| Jones, N | 1 |
1 review available for dapsone and Alzheimer Disease
| Article | Year |
|---|---|
Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Dapsone; Drug Therapy, Combination; Humans; Ibuprofen; Inflammation; Min | 2019 |
3 other studies available for dapsone and Alzheimer Disease
| Article | Year |
|---|---|
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
Topics: Alzheimer Disease; Clofazimine; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dapsone; Hu | 2020 |
Primary systemic amyloidoses: possible new directions in prophylaxis and therapy.
Topics: Alzheimer Disease; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dementia; Humans; | 1996 |
Soothing the inflamed brain.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Encephalitis; Humans | 2000 |